JP Morgan Maintains Neutral on Agios Pharmaceuticals, Raises Price Target to $25

Benzinga · 6d ago
JP Morgan analyst Tessa Romero maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Neutral and raises the price target from $20 to $25.